Medical University of South Carolina: Division of Rheumatology & Immunology
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Silver, Richard
NCT04781543 / 2020-005764-62: A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis

Calendar Jan 2024 - Dec 2024: Data from trial for diffuse cutaneous systemic sclerosis
Recruiting
2
300
Europe, Japan, US, RoW
HZN-825 BID, Placebo, HZN-825 QD
Amgen
Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic
10/24
09/25
BRAVOS, NCT03222492: Brentuximab Vedotin for Systemic Sclerosis

Completed
1/2
17
US
Brentuximab Vedotin, Adcetris®, Placebo, Placebo for brentuximab vedotin
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), Seagen Inc., PPD, Rho Federal Systems Division, Inc.
Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc
04/23
04/23
SUMMIT, NCT04153864: Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment

Active, not recruiting
N/A
1230
Canada, US
Brief Behavioral Activation Treatment, Brief evidence-based Psychological Treatment of BA for perinatal depressive and anxiety symptoms
Mount Sinai Hospital, Canada, University of North Carolina, Chapel Hill, NorthShore University HealthSystem, Women's College Hospital, Unity Health Toronto, Sunnybrook Health Sciences Centre, University of Colorado, Boulder, Harvard Medical School (HMS and HSDM), Patient-Centered Outcomes Research Institute
Perinatal Depression
02/24
03/25
Wilson, Nathan
NCT04901806: Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

Terminated
1
29
Europe, US, RoW
PBI-200
Pyramid Biosciences
Solid Tumor, Adult, Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor
07/23
07/23
Fash, Jordan
MINDS-CAD, NCT04837846: Multicenter Study Into Individualized Scanning for Coronary Artery Disease

Recruiting
N/A
300
US
Differing Tube Voltage Administration
Medical University of South Carolina
Coronary Artery Disease
12/24
12/24
Frasier, Brittany
BRAVOS, NCT03222492: Brentuximab Vedotin for Systemic Sclerosis

Completed
1/2
17
US
Brentuximab Vedotin, Adcetris®, Placebo, Placebo for brentuximab vedotin
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), Seagen Inc., PPD, Rho Federal Systems Division, Inc.
Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc
04/23
04/23

Download Options